Vertex to Participate in Upcoming September Investor Conferences
Vertex Pharmaceuticals (Nasdaq: VRTX) has announced its participation in two upcoming investor conferences in September 2024. Dr. Reshma Kewalramani, CEO and President, and Charles Wagner, EVP and CFO, will engage in a fireside chat at the Morgan Stanley 22nd Annual Global Healthcare Conference on September 5 at 11:30 a.m. ET. Additionally, Susie Lisa, SVP of Investor Relations, and Manisha Pai, Executive Director of Investor Relations, will participate in a fireside chat at the Cantor Global Healthcare Conference on September 17 at 9:10 a.m. ET.
Both events will be webcast live through the Vertex website's Investors section. Replays of the conference webcasts will be archived on the company's website for future reference.
Vertex Pharmaceuticals (Nasdaq: VRTX) ha annunciato la propria partecipazione a due conferenze per investitori in programma per settembre 2024. Dr. Reshma Kewalramani, CEO e Presidente, e Charles Wagner, EVP e CFO, parteciperanno a una discussione informale durante la 22ª Conferenza Annuale sulla Salute Globale di Morgan Stanley il 5 settembre alle 11:30 ET. Inoltre, Susie Lisa, SVP delle Relazioni con gli Investitori, e Manisha Pai, Direttore Esecutivo delle Relazioni con gli Investitori, prenderanno parte a una discussione informale alla Conferenza sulla Salute Globale di Cantor il 17 settembre alle 9:10 ET.
Entrambi gli eventi saranno trasmessi in diretta tramite la sezione Investitori del sito web di Vertex. Le registrazioni delle trasmissioni delle conferenze saranno archiviate sul sito dell'azienda per una futura consultazione.
Vertex Pharmaceuticals (Nasdaq: VRTX) ha anunciado su participación en dos conferencias de inversores que se celebrarán en septiembre de 2024. Dr. Reshma Kewalramani, CEO y Presidente, y Charles Wagner, EVP y CFO, participarán en una charla informal en la 22ª Conferencia Anual de Salud Global de Morgan Stanley el 5 de septiembre a las 11:30 a.m. ET. Además, Susie Lisa, SVP de Relaciones con Inversores, y Manisha Pai, Directora Ejecutiva de Relaciones con Inversores, participarán en una charla informal en la Conferencia de Salud Global de Cantor el 17 de septiembre a las 9:10 a.m. ET.
Ambos eventos se transmitirán en vivo a través de la sección de Inversores del sitio web de Vertex. Las repeticiones de las conferencias se archivarán en el sitio web de la empresa para referencia futura.
Vertex Pharmaceuticals (Nasdaq: VRTX)는 2024년 9월에 예정된 두 개의 투자자 회의에 참석할 예정이라고 발표했습니다. Dr. Reshma Kewalramani, CEO이자 회장, 및 Charles Wagner, EVP 및 CFO가 9월 5일 오전 11시 30분 ET에 모건 스탠리 제22회 글로벌 헬스케어 회의에서 편안한 대화를 나눌 예정입니다. 또한 Susie Lisa, 투자자 관계 부사장, 및 Manisha Pai, 투자자 관계 전무 이사가 9월 17일 오전 9시 10분 ET에 칸토 글로벌 헬스케어 회의에서 대화에 참여할 것입니다.
두 이벤트 모두 실시간으로 방송될 예정이며, Vertex 웹사이트의 투자자 섹션을 통해 진행됩니다. 회의 방송 기록은 향후 참조를 위해 회사 웹사이트에 보관될 것입니다.
Vertex Pharmaceuticals (Nasdaq: VRTX) a annoncé sa participation à deux conférences d'investisseurs prévues en septembre 2024. Dr. Reshma Kewalramani, PDG et Présidente, et Charles Wagner, EVP et CFO, participeront à une discussion informelle lors de la 22e Conférence Annuelle Mondiale sur la Santé de Morgan Stanley le 5 septembre à 11h30 ET. De plus, Susie Lisa, SVP des Relations avec les Investisseurs, et Manisha Pai, Directrice Exécutive des Relations avec les Investisseurs, prendront part à une discussion informelle lors de la Conférence Mondiale sur la Santé de Cantor le 17 septembre à 9h10 ET.
Les deux événements seront diffusés en direct via la section Investisseurs du site web de Vertex. Les rediffusions des conférences seront archivées sur le site de l'entreprise pour référence future.
Vertex Pharmaceuticals (Nasdaq: VRTX) hat seine Teilnahme an zwei bevorstehenden Investorenkonferenzen im September 2024 bekannt gegeben. Dr. Reshma Kewalramani, CEO und Präsidentin, sowie Charles Wagner, EVP und CFO, werden am 5. September um 11:30 Uhr ET an einem informellen Gespräch auf der 22. Jahreskonferenz für globale Gesundheitsversorgung von Morgan Stanley teilnehmen. Zusätzlich werden Susie Lisa, SVP für Investorenbeziehungen, und Manisha Pai, Executive Director für Investorenbeziehungen, am 17. September um 9:10 Uhr ET an einem informellen Gespräch auf der Cantor Global Healthcare Conference teilnehmen.
Beide Veranstaltungen werden live übertragen über den Bereich Investoren auf der Website von Vertex. Die Wiederholungen der Konferenzübertragungen werden auf der Website des Unternehmens für zukünftige Verweise archiviert.
- None.
- None.
- Dr. Reshma Kewalramani, Chief Executive Officer and President, and Charles Wagner, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the Morgan Stanley 22nd Annual Global Healthcare Conference on Thursday, September 5, 2024 at 11:30 a.m. ET.
- Susie Lisa, Senior Vice President of Investor Relations and Manisha Pai, Executive Director of Investor Relations, will participate in a fireside chat at the Cantor Global Healthcare Conference on Tuesday, September 17, 2024 at 9:10 a.m. ET.
A live webcast of management's remarks will be available through the Vertex website, www.vrtx.com in the "Investors" section under the "News and Events" page. A replay of the conference webcast will be archived on the company's website.
About Vertex
Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has approved medicines that treat the underlying causes of multiple chronic, life-shortening genetic diseases — cystic fibrosis, sickle cell disease and transfusion-dependent beta thalassemia — and continues to advance clinical and research programs in these diseases. Vertex also has a robust clinical pipeline of investigational therapies across a range of modalities in other serious diseases where it has deep insight into causal human biology, including acute and neuropathic pain, APOL1-mediated kidney disease, IgA nephropathy, autosomal dominant polycystic kidney disease, type 1 diabetes, myotonic dystrophy type 1 and alpha-1 antitrypsin deficiency.
Vertex was founded in 1989 and has its global headquarters in
(VRTX-WEB)
View source version on businesswire.com: https://www.businesswire.com/news/home/20240822736102/en/
Vertex Pharmaceuticals Incorporated
Investors:
InvestorInfo@vrtx.com
Source: Vertex Pharmaceuticals Incorporated
FAQ
When is Vertex Pharmaceuticals (VRTX) participating in the Morgan Stanley Global Healthcare Conference?
Who will represent Vertex Pharmaceuticals (VRTX) at the Cantor Global Healthcare Conference?
Where can investors access the webcast of Vertex Pharmaceuticals' (VRTX) conference presentations?
Will replays of Vertex Pharmaceuticals' (VRTX) investor conference webcasts be available?
